tiprankstipranks
Trending News
More News >
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
Sweden Market

Xbrane Biopharma AB (XBRANE) Ratios

Compare
10 Followers

Xbrane Biopharma AB Ratios

SE:XBRANE's free cash flow for Q4 2025 was kr-0.12. For the 2025 fiscal year, SE:XBRANE's free cash flow was decreased by kr and operating cash flow was kr-2.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
7.12 7.12 1.13 1.41 2.17
Quick Ratio
3.43 3.43 0.67 1.09 1.96
Cash Ratio
1.64 1.64 0.23 0.20 0.82
Solvency Ratio
1.28 1.28 -0.36 -0.76 -0.59
Operating Cash Flow Ratio
-4.76 -4.76 -0.25 -1.25 -0.82
Short-Term Operating Cash Flow Coverage
0.00 0.00 -1.62 -6.51 0.00
Net Current Asset Value
kr 264.16Mkr 264.16Mkr -27.99Mkr -20.48Mkr 247.90M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.09 0.23 0.35 0.06
Debt-to-Equity Ratio
0.10 0.10 0.92 1.35 0.09
Debt-to-Capital Ratio
0.09 0.09 0.48 0.57 0.08
Long-Term Debt-to-Capital Ratio
0.09 0.09 0.24 0.40 0.00
Financial Leverage Ratio
1.20 1.20 4.04 3.81 1.63
Debt Service Coverage Ratio
-1.47 -1.19 -1.63 -4.35 -57.82
Interest Coverage Ratio
-1.63 -1.98 -6.05 -136.75 -64.35
Debt to Market Cap
0.80 <0.01 0.75 0.07 0.00
Interest Debt Per Share
0.16 0.05 23.15 115.39 22.61
Net Debt to EBITDA
1.36 1.71 -0.37 -0.59 1.04
Profitability Margins
Gross Profit Margin
55.13%49.19%90.83%14.82%71.23%
EBIT Margin
-17.27%-20.41%-109.67%-127.14%-287.97%
EBITDA Margin
-13.62%-10.83%-91.58%-118.14%-259.20%
Operating Profit Margin
-16.78%-20.41%-109.67%-130.03%-288.48%
Pretax Profit Margin
-28.84%-28.84%-127.54%-134.89%-292.47%
Net Profit Margin
83.52%83.52%-133.98%-162.60%-298.91%
Continuous Operations Profit Margin
-30.30%-30.30%-133.38%-134.89%-292.47%
Net Income Per EBT
-289.63%-289.63%105.05%120.54%102.20%
EBT Per EBIT
171.88%141.27%116.29%103.74%101.38%
Return on Assets (ROA)
18.95%18.95%-31.60%-59.40%-24.94%
Return on Equity (ROE)
29.10%22.70%-127.66%-226.56%-40.53%
Return on Capital Employed (ROCE)
-4.13%-5.02%-71.57%-94.95%-36.62%
Return on Invested Capital (ROIC)
-4.13%-5.02%-54.45%-77.06%-35.89%
Return on Tangible Assets
33.92%33.92%-39.46%-70.09%-29.26%
Earnings Yield
4.56%0.82%-134.61%-15.33%-0.93%
Efficiency Ratios
Receivables Turnover
12.39 12.39 0.85 3.35 1.21
Payables Turnover
7.63 8.64 0.08 6.56 0.71
Inventory Turnover
0.35 0.40 0.07 1.90 0.33
Fixed Asset Turnover
4.23K 4.23K 3.06 2.71 0.81
Asset Turnover
0.23 0.23 0.24 0.37 0.08
Working Capital Turnover Ratio
0.50 0.78 1.96 1.16 0.19
Cash Conversion Cycle
1.02K 903.26 514.17 245.04 894.35
Days of Sales Outstanding
29.47 29.47 427.42 108.83 300.63
Days of Inventory Outstanding
1.04K 916.02 4.94K 191.81 1.11K
Days of Payables Outstanding
47.81 42.22 4.86K 55.60 512.99
Operating Cycle
1.07K 945.48 5.37K 300.63 1.41K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.54 -0.16 -13.59 -200.76 -107.47
Free Cash Flow Per Share
-0.70 -0.16 -18.90 -209.04 -140.79
CapEx Per Share
0.16 0.00 5.31 8.28 33.32
Free Cash Flow to Operating Cash Flow
1.29 1.00 1.39 1.04 1.31
Dividend Paid and CapEx Coverage Ratio
-3.44 0.00 -2.56 -24.25 -3.23
Capital Expenditure Coverage Ratio
-3.44 0.00 -2.56 -24.25 -3.23
Operating Cash Flow Coverage Ratio
-4.30 -4.30 -0.70 -1.76 -5.07
Operating Cash Flow to Sales Ratio
-1.65 -1.65 -0.67 -1.70 -3.37
Free Cash Flow Yield
-443.13%-1.62%-94.04%-16.72%-1.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.92 121.99 -0.74 -6.52 -107.52
Price-to-Sales (P/S) Ratio
0.48 101.88 1.00 10.61 321.39
Price-to-Book (P/B) Ratio
4.98 27.69 0.95 14.78 43.58
Price-to-Free Cash Flow (P/FCF) Ratio
-0.23 -61.92 -1.06 -5.98 -72.89
Price-to-Operating Cash Flow Ratio
-11.13 -61.92 -1.48 -6.23 -95.49
Price-to-Earnings Growth (PEG) Ratio
0.46 -1.22 <0.01 -0.10 7.44
Price-to-Fair Value
4.98 27.69 0.95 14.78 43.58
Enterprise Value Multiple
-2.16 -939.14 -1.46 -9.57 -122.95
Enterprise Value
44.75M 15.49B 265.16M 2.70B 18.36B
EV to EBITDA
-2.16 -939.14 -1.46 -9.57 -122.95
EV to Sales
0.29 101.70 1.33 11.30 318.68
EV to Free Cash Flow
-0.14 -61.81 -1.43 -6.37 -72.28
EV to Operating Cash Flow
-0.18 -61.81 -1.98 -6.63 -94.69
Tangible Book Value Per Share
1.21 0.37 4.15 35.38 178.95
Shareholders’ Equity Per Share
1.21 0.37 21.19 84.58 235.47
Tax and Other Ratios
Effective Tax Rate
-0.05 -0.05 -0.05 0.00 0.00
Revenue Per Share
0.33 0.10 20.19 117.85 31.93
Net Income Per Share
0.27 0.08 -27.06 -191.63 -95.45
Tax Burden
-2.90 -2.90 1.05 1.21 1.02
Interest Burden
1.67 1.41 1.16 1.06 1.02
Research & Development to Revenue
0.50 0.50 1.57 1.28 3.47
SG&A to Revenue
0.19 0.00 0.20 0.17 0.55
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 0.15
Income Quality
-1.93 5.43 0.50 1.05 1.12
Currency in SEK